Ovarian Hyperstimulation Syndrome
📧 Sign up to get email alerts when something new happens for Ovarian Hyperstimulation Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Ovarian Hyperstimulation Syndrome and Cabergoline [NA]
This clinical trial update reports on a completed study evaluating cabergoline for ovarian hyperstimulation syndrome, including subjects wit…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome [NA]
This clinical trial update indicates that the study on the effect of human albumin infusion on VEGF levels in women at risk for ovarian hype…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating cabergoline and hydroxyethyl starch for prevention of ovarian hyperstimulation syndrome has compl…
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS
A completed clinical trial evaluated whether a double daily dose of a GnRH antagonist could prevent ovarian hyperstimulation syndrome in hyp…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating methylprednisolone to prevent ovarian hyperstimulation syndrome has completed, sponsored by Royan Instit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide [Phase 2]
A Phase 2 trial evaluating three oral doses of quinagolide over three weeks for ovarian hyperstimulation syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome [Phase 2]
Phase 2 trial update on the tolerability of quinagolide given in a dose-titration regimen for oocyte donors at risk of ovarian hyperstimulat…
-
CLINICAL_TRIALS trial_result · 2008-12-17Clinical Trial Update: In Vitro Maturation of Immature Oocytes [NA]
Clinical trial update for in vitro maturation of immature oocytes sponsored by Sheba Medical Center; the study has completed and addresses P…
-
CLINICAL_TRIALS research · 2008-10-29Clinical Trial Update: 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" [NA]
Clinical trial update on the SPRING study evaluating subfertility guidelines implementation in the Netherlands among gynecologists. Conditio…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Cabergoline Reduces OHSS [Phase 3]
Phase 3 trial results indicate that cabergoline reduces the risk of ovarian hyperstimulation syndrome in patients undergoing fertility treat…
-
CLINICAL_TRIALS trial_result · 2006-12-29Clinical Trial Update: Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients [Phase 4]
Phase 4 clinical trial update comparing GnRH agonist versus GnRH antagonist protocols for ovarian stimulation in patients with polycystic ov…
-
CLINICAL_TRIALS trial_result · 2006-07-06Clinical Trial Update: The Use of GnRH Agonist Trigger in the Prevention of OHSS [Phase 4]
A Phase 4 clinical trial update evaluates using a GnRH agonist trigger to prevent ovarian hyperstimulation syndrome. The study status is com…